Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001731122-21-000561
Filing Date
2021-04-09
Accepted
2021-04-09 17:06:46
Documents
3
Effectiveness Date
2021-04-09

Document Format Files

Seq Description Document Type Size
1 e2594_s8.htm S-8 60235
2 EXHIBIT 5.1 e2594_ex5-1.htm EX-5.1 8421
3 e2594_ex231.htm EX-23.1 3329
  Complete submission text file 0001731122-21-000561.txt   73125
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: S-8 | Act: 33 | File No.: 333-255166 | Film No.: 21818485
SIC: 8731 Services-Commercial Physical & Biological Research